Oophorectomy in Premenopausal Patients with Estrogen Receptor-Positive Breast Cancer: New Insights into Long-Term Effects

Approximately 80% of breast cancers are estrogen receptor-positive (ER+), and 68–80% of those occur in premenopausal or perimenopausal women. Since the introduction of tamoxifen for adjuvant endocrine therapy in women with non-metastatic ER+ breast cancer, subsequent trials have demonstrated an onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Fatima, Rojas, Kristin, Schlumbrecht, Matthew, Jeudin, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954995/
https://www.ncbi.nlm.nih.gov/pubmed/36826100
http://dx.doi.org/10.3390/curroncol30020139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954995/
https://www.ncbi.nlm.nih.gov/pubmed/36826100
http://dx.doi.org/10.3390/curroncol30020139

Ejemplares similares